You have 9 free searches left this month | for more free features.

glycosaminoglycans

Showing 1 - 25 of 131

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Respiratory Cathepsins, Proteases Inhibitors and

Completed
  • Mucopolysaccharidoses
  • Sputum
  • Tracheal aspiration
  • Angers, France
  • +6 more
Jan 3, 2022

AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication

Recruiting
  • Muscle-Invasive Bladder Carcinoma
  • GAG score
  • Roskilde, Denmark
  • +2 more
Jun 21, 2022

Mucopolysaccharidosis II Trial (Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII)

Not yet recruiting
  • Mucopolysaccharidosis II
  • Autologous CD34+ HSCs transduced ex vivo with CD11B LV encoding human IDS tagged with ApoEII
  • (no location specified)
Dec 16, 2022

Mucopolysaccharidosis Type II Natural History

Completed
  • Mucopolysaccharidosis II
    • Pittsburgh, Pennsylvania
    • +2 more
    Apr 22, 2022

    MPS I Trial in Oakland (SB-318)

    Terminated
    • MPS I
    • SB-318
    • Oakland, California
      UCSF Benioff Children's Hospital Oakland
    Jan 6, 2023

    MPS IIIA, Sanfilippo Syndrome, Sanfilippo A Trial in Australia, Spain, United States (ABO-102)

    Active, not recruiting
    • MPS IIIA
    • +3 more
    • ABO-102
    • Columbus, Ohio
    • +4 more
    Nov 8, 2022

    Chronic Heart Failure Trial in Amsterdam (Endocalyx Pro, )

    Recruiting
    • Chronic Heart Failure
    • Endocalyx Pro
    • placebo
    • Amsterdam, Noord-Holland, Netherlands
      Amsterdam UMC
    Jul 21, 2023

    MPS-IH (Hurler Syndrome) Trial in Worldwide (Experimental: OTL-203, Active Comparator: Allo-HSCT)

    Not yet recruiting
    • MPS-IH (Hurler Syndrome)
    • Experimental: OTL-203
    • Active Comparator: Allo-HSCT
    • Oakland, California
    • +6 more
    Nov 27, 2023

    Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome Trial in Rome (Aldurazyme (laronidase))

    Recruiting
    • Mucopolysaccharidosis I
    • +3 more
    • Aldurazyme (laronidase)
    • Rome, Italy
      Dipartimento di Scienze Pediatriche Medico - Chirurgiche e Neuro
    Mar 28, 2022

    Mucopolysaccharidosis I, Mucopolysaccharidosis II, Mucopolysaccharidosis IV A Trial in San Francisco (There is no intervention)

    Recruiting
    • Mucopolysaccharidosis I
    • +7 more
    • There is no intervention
    • San Francisco, California
      University of California San Francisco
    Nov 9, 2022

    LEVANTIS-0093A: GAGomes for Multi-Cancer Early Detection in

    Recruiting
    • Cancer
      • Leeds, United Kingdom
        Leads Teaching Hospitals Trust
      Mar 15, 2022

      Hypertension Trial in Cambridge, London (Amlodipine, Chlortalidone)

      Not yet recruiting
      • Hypertension
      • Cambridge, United Kingdom
      • +1 more
      Jul 27, 2023

      MPS I, MPS1-S, MPS1-HS Trial in Porto Alegre, London, Salford (SIG-005 (hIDUA Producing Spheres))

      Withdrawn
      • MPS I
      • +2 more
      • SIG-005 (hIDUA Producing Spheres)
      • Porto Alegre, Brazil
      • +2 more
      Dec 16, 2022

      MPS IVA, MPS VI Trial in Oakland (Vosoritide Injection [Voxzogo])

      Not yet recruiting
      • MPS IVA
      • MPS VI
      • Vosoritide Injection [Voxzogo]
      • Oakland, California
        UCSF Benioff Children's Hospital Oakland
      May 4, 2023

      Iris Cameras in Mucopolysaccharidoses

      Not yet recruiting
      • Mucopolysaccharidoses
      • Imaging
      • Manchester, United Kingdom
        Manchester University NHS Foundation Trust
      Aug 30, 2022

      Burns Trial in Aurora (Fresh Frozen Plasma)

      Recruiting
      • Burns
      • Fresh Frozen Plasma
      • Aurora, Colorado
        University of Colorado Denver Anschutz Medical Campus
      Feb 22, 2022

      Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome, Hurler-Scheie Syndrome Trial in Orange, Philadelphia, Porto Alegre

      Active, not recruiting
      • Mucopolysaccharidosis Type I (MPS I)
      • +2 more
      • RGX-111
      • Orange, California
      • +3 more
      Jan 9, 2023

      Mucopolysaccharidosis II, MPS II Trial in United States (SB-913)

      Terminated
      • Mucopolysaccharidosis II
      • MPS II
      • SB-913
      • Oakland, California
      • +4 more
      Oct 21, 2022

      Mucopolysaccharidosis Type IIIA Trial in Manchester (Autologous CD34+ cells transduced with a lentiviral vector containing the

      Active, not recruiting
      • Mucopolysaccharidosis Type IIIA
      • Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene
      • Manchester, United Kingdom
        Manchester University NHS Foundation Trust
      Jul 2, 2021

      Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,

      Recruiting
      • Systemic Amyloidosis
      • 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
      • 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
      • Knoxville, Tennessee
        University of Tennessee Graduate School of Medicine
      Jul 10, 2023

      Rhytides Trial in San Francisco (AmnioFix plus Standard of Care, Standard of Care)

      Withdrawn
      • Rhytides
      • AmnioFix plus Standard of Care
      • Standard of Care
      • San Francisco, California
        UCSF Dermatology
      Mar 7, 2022

      Water and Electrolytes Content in HYpertension (WHYSKI) in SKIn

      Recruiting
      • Hyperaldosteronism
      • +7 more
      • Skin Biopsy
      • Video-laparoscopic adrenalectomy
      • Padova, Italy
        Azienda Ospedale Università di Padova
      Oct 23, 2023

      LEVANTIS-0087A: GAGomes for Multi-Cancer Early Detection in

      Recruiting
      • Cancer
      • Combined free GAGome MCED test
      • Stockholm, Sweden
        Elypta AB
      Mar 29, 2022

      Hunter Syndrome Trial in Lexington

      Recruiting
      • Hunter Syndrome
        • Lexington, Massachusetts
          Shire
        Nov 7, 2022